UMIN-CTR Clinical Trial
| Unique ID issued by UMIN | UMIN000060779 |
|---|---|
| Receipt number | R000069539 |
| Scientific Title | Myofascial Release of the Spiral Muscle Chain: Immediate Effects on Knee and Ankle Range of Motion, Balance, and Q Angle in Individuals with Genu Valgum. A Randomized Controlled Trial |
| Date of disclosure of the study information | 2026/03/01 |
| Last modified on | 2026/02/27 17:43:42 |
* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments
Basic information
Public title
Myofascial Release of the Spiral Muscle Chain: Immediate Effects on Knee and Ankle Range of Motion, Balance, and Q Angle in Individuals with Genu Valgum. A Randomized Controlled Trial
Acronym
Myofascial Release of the Spiral Muscle Chain: Immediate Effects on Knee and Ankle Range of Motion, Balance, and Q Angle in Individuals with Genu Valgum. A Randomized Controlled Trial
Scientific Title
Myofascial Release of the Spiral Muscle Chain: Immediate Effects on Knee and Ankle Range of Motion, Balance, and Q Angle in Individuals with Genu Valgum. A Randomized Controlled Trial
Scientific Title:Acronym
Myofascial Release of the Spiral Muscle Chain: Immediate Effects on Knee and Ankle Range of Motion, Balance, and Q Angle in Individuals with Genu Valgum. A Randomized Controlled Trial
Region
| Asia(except Japan) |
Condition
Condition
pre-post
Classification by specialty
| Rehabilitation medicine | Adult |
Classification by malignancy
Malignancy
Genomic information
NO
Objectives
Narrative objectives1
To evaluate the immediate effects of a single session of myofascial release (MFR) targeting the spiral muscle chain on knee flexion ROM, ankle dorsiflexion and plantarflexion ROM, static and dynamic balance, and Q-angle in adults with genu valgum, compared with a no-intervention control group.
Basic objectives2
Others
Basic objectives -Others
compared with a no-intervention control group.
Trial characteristics_1
Trial characteristics_2
Developmental phase
Assessment
Primary outcomes
Q-angle
Key secondary outcomes
knee flexion ROM, ankle dorsiflexion and plantarflexion ROM, static and dynamic balance
Base
Study type
Interventional
Study design
Basic design
Parallel
Randomization
Randomized
Randomization unit
Individual
Blinding
Single blind -investigator(s) and assessor(s) are blinded
Control
No treatment
Stratification
Dynamic allocation
Institution consideration
Blocking
Concealment
Intervention
No. of arms
2
Purpose of intervention
Treatment
Type of intervention
| Other |
Interventions/Control_1
MFR group
Interventions/Control_2
control group
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10
Eligibility
Age-lower limit
| 30 | years-old | <= |
Age-upper limit
| 50 | years-old | >= |
Gender
Male and Female
Key inclusion criteria
Adults aged 30-50 years
- Confirmed genu valgum defined as medial malleoli distance of 8-12 cm while standing with knees touching (measured by digital caliper)
- No recent (within six months) lower limb injuries
- No neurological disorders
- No other musculoskeletal conditions affecting the lower extremities
Key exclusion criteria
physical activity within 72 hours prior to testing, use of medications affecting muscle function or balance (e.g., muscle relaxants, sedatives), or inability to comply with the protocol (e.g., inability to maintain required positions or follow instructions).
Target sample size
140
Research contact person
Name of lead principal investigator
| 1st name | Borhan |
| Middle name | |
| Last name | Shariati Sabet |
Organization
University of Babol
Division name
UB
Zip code
4717647745
Address
Babol, Iran
TEL
989336487376
borhan_shariati@yahoo.com
Public contact
Name of contact person
| 1st name | Borhan |
| Middle name | |
| Last name | Shariati Sabet |
Organization
University of Babol
Division name
ub
Zip code
4717647745
Address
Babol, Iran
TEL
989336487376
Homepage URL
borhan_shariati@yahoo.com
Sponsor or person
Institute
self funding
Institute
Department
Personal name
Funding Source
Organization
self funding
Organization
Division
Category of Funding Organization
Self funding
Nationality of Funding Organization
Other related organizations
Co-sponsor
Name of secondary funder(s)
IRB Contact (For public release)
Organization
shahrood
Address
shahrood
Tel
989336487376
a.mehmandoust@mail.sbu.ac.ir
Secondary IDs
Secondary IDs
NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW
Institutions
Institutions
Other administrative information
Date of disclosure of the study information
| 2026 | Year | 03 | Month | 01 | Day |
Related information
URL releasing protocol
Publication of results
Unpublished
Result
URL related to results and publications
Number of participants that the trial has enrolled
Results
Results date posted
Results Delayed
Results Delay Reason
Date of the first journal publication of results
Baseline Characteristics
Participant flow
Adverse events
Outcome measures
Plan to share IPD
IPD sharing Plan description
Progress
Recruitment status
Preinitiation
Date of protocol fixation
| 2026 | Year | 03 | Month | 02 | Day |
Date of IRB
| 2026 | Year | 01 | Month | 08 | Day |
Anticipated trial start date
| 2026 | Year | 03 | Month | 04 | Day |
Last follow-up date
| 2026 | Year | 03 | Month | 10 | Day |
Date of closure to data entry
Date trial data considered complete
Date analysis concluded
Other
Other related information
Management information
Registered date
| 2026 | Year | 02 | Month | 27 | Day |
Last modified on
| 2026 | Year | 02 | Month | 27 | Day |
Link to view the page
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000069539
